Article
<i>In vivo</i> expression of survivin and its splice variant survivin‐2B: Impact on clinical outcome in acute myeloid leukemia
17 Apr 2006
Abstract excerpt
Survivin, a member of the inhibitor of apoptosis protein family, is expressed in most human cancers, but undetectable in normal differentiated adult tissue in vivo. Because of this cancer-related expression, survivin is a promising target for cancer therapy. To determine the expression and prognostic role of survivin in acute myeloid leukemia (AML), we investigated the mRNA expression pattern of survivin and of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
